MAM
MPM Asset Management Portfolio holdings
AUM
$43.3M
This Quarter Return
-15.41%
1 Year Return
-54.44%
3 Year Return
+14.05%
5 Year Return
-29.8%
10 Year Return
-11.6%
AUM
$43.3M
AUM Growth
+$43.3M
(-38%)
Cap. Flow
-$16.5M
Cap. Flow
% of AUM
-38.01%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
1
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
iTeos Therapeutics
ITOS
|
$16.4M |
| 2 |
ADAP
Adaptimmune Therapeutics
ADAP
|
$126K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Entrada Therapeutics
TRDA
$208M
| $29.4M | 67.92% | 4,381,062 | – | – |
|
2
Dyne Therapeutics
DYN
$1.92B
| $6.5M | 14.99% | 682,376 | – | – |
|
3
Werewolf Therapeutics
HOWL
$59.9M
| $4.7M | 10.84% | 4,309,860 | – | – |
|
4
Repare Therapeutics
RPTX
$71.7M
| $1.56M | 3.6% | 1,121,318 | – | – |
|
|
ADAP
5
Adaptimmune Therapeutics
ADAP
$15.6M
| $1.15M | 2.66% | 4,809,677 -526,038 | -10% | -$126K |
|
|
6
iTeos Therapeutics
ITOS
| – | – | -2,738,785 | Closed | -$16.4M |
|